...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >A score predicting survival after liver retransplantation for hepatitis C virus cirrhosis
【24h】

A score predicting survival after liver retransplantation for hepatitis C virus cirrhosis

机译:预测丙肝病毒肝硬化肝移植后存活率的评分

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background. Approximately one fourth of patients transplanted for hepatitis C virus (HCV)-induced liver failure progress to cirrhosis within 5 years, potentially requiring retransplantation. Although the relisting decision can be difficult in these patients, a score could help in selection of candidates with the best potential outcomes. Methods. A total of 1422 HCV-positive patients having undergone a retransplantation were included in this registry-based study. A multivariate Cox regression was performed, and an Akaike procedure was applied to design a score predicting survival after retransplantation and to allow an internal validation. Retained variables were donor age (DnAge), serum creatinine (Creat), International Normalized Ratio (INR), and serum albumin (Alb) at the second transplantation, recipient age (RecAge) at the first transplantation, and the interval between both transplantations (Int). Results. The score was designed as 0.23×DnAge+4.86×log Creat-2.45×log Int+2.69×INR+0.10×RecAge-3.27× Alb+40. The receiver operating characteristic area under curve was 0.643 at 3 years, and survivals were 71%, 56%, and 37% for scores <30, 30 to 40, and >40, respectively (log rank <0.0001). Conclusions. Overall, the proposed score is specifically designed for HCV-positive patients, accurately predicts survival after a liver retransplantation, and is helpful in the selection of candidates with the best potential outcomes.
机译:背景。因丙型肝炎病毒(HCV)引起的肝衰竭而移植的患者中,大约四分之一在5年内发展为肝硬化,可能需要重新移植。尽管在这些患者中重新决定可能很困难,但评分可能有助于选择具有最佳潜在结果的候选人。方法。这项基于注册表的研究共纳入了1422例再次移植的HCV阳性患者。进行多变量Cox回归,并应用Akaike程序设计评分,以预测移植后的存活率并进行内部验证。保留的变量是第二次移植的供体年龄(DnAge),血清肌酐(Creat),国际标准化比率(INR)和血清白蛋白(Alb),第一次移植的受体年龄(RecAge)以及两次移植之间的间隔( Int)。结果。分数设计为0.23×DnAge + 4.86×log Creat-2.45×log Int + 2.69×INR + 0.10×RecAge-3.27×Alb + 40。接受者在曲线下的工作特征区域在3年时为0.643,对于得分<30、30至40和> 40,生存率分别为71%,56%和37%(对数等级<0.0001)。结论。总体而言,提议的分数是专为HCV阳性患者设计的,可准确预测肝移植后的存活率,并有助于选择具有最佳潜在结局的候选人。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号